NSE: SOLARA - Solara Active Pharma Sciences Limited

Yield per half year: +16.94%
Sector: Healthcare

Solara Active Pharma Sciences Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 59.63 -100% -5.07 -100%
P/S 1.2 9.32 -87.11%
P/BV 1.59 6.64 -76.07%
P/FCF 19.55 -106.44 -118.37%
Ev/Ebitda -8.83 141.59 -106.23%
Ev/S 2.01 9.59 -79.03%
Ev/FCF 36.73 -85.26 -143.08%
E/P -0.4279 0.0211 -2130.43%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-22.79 5.56 -510.01% 8.44 -370.02%
ROE -46.62 10.72 -534.69%
ROA -21.61 7.64 -383%
ROIC 0 15.91 -100%
ROS -45.82 -4.5 918.02%
ROCE -34.73 13.07 -365.64%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-3.58 121.74 -102.94% 2.54 -241.2%
Nеt Debt/Ebitda -3.55 121.47 -102.93%
Debt/Ratio 0.4302 0.145 196.63%
Debt/Equity 0.8727 1.97 -55.6%
Debt/Net Income -1.78 5.06 -135.2%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 9.57 -100% 0.6779 -100%
Number of years of dividend growth 0 0.9146 -100%
DSI 0.625 0.8306 -24.76%
Average dividend growth -16.67 -3.39 391.94%
Average percentage for 5 years 0.6779 14.83 -95.43%
Average percentage for payments 845.56 24.67 3327.42%
Difference from average difference in sector -9.57

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-2.31 42.4 -105.45%
Growth impulse Ebitda in 5 years -204.34 26.84 -861.33%
Growth impulse Net Income in 5 years -595.06 77.79 -864.96%
Growth impulse FCF in 5 years -375.09 -25.16 1390.82%
Growth impulse EPS in 5 years -439.25 -13.77 3089.91%
IP Score
3.17/10

Similar companies

Mankind Pharma Limited

Apollo Hospitals Enterprise Limited

IndusInd Bank Limited

Aurobindo Pharma Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription